Dr. Rana McKay on the benefits of the ArteraAI Prostate Test
In this video, Rana R. McKay, MD, discusses the benefits of ArteraAI in prostate cancer. McKay is a medical oncologist and as [...]
Balancing Innovation and the Ethical Adoption of AI in Healthcare
In recent years, the rapid advancement of artificial intelligence (AI) has created a wave of excitement and anticipation with [...]
Unlocking the power of health care AI tools through clinical validation
Artificial intelligence (AI) has emerged as a game-changing technology with the potential to revolutionize health care. Speci [...]
AI-Derived Model Identifies Prostate Cancer Patients Likely to Benefit From ADT
An artificial intelligence (AI)-derived model can identify prostate cancer patients who are likely to benefit from short-term [...]
AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer
Artificial intelligence (AI) may predict which patients with intermediate-risk prostate cancer will benefit from short-term a [...]
Novel AI Model Predicts ADT Benefit in Patients With Prostate Cancer
Results of a phase 3 randomized trial published in NEJM Evidence suggest a novel artificial intelligence (AI) model may help [...]
ASCO 2023: Digital Histopathology-Based Multimodal Artificial Intelligence Scores Predict Risk of Progression in a Randomized Phase III Trial in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
Dr. Felix Feng presented on the use of digital histopathology-based multimodal artificial intelligence scores to predict risk [...]
Dr. McKay highlights the ArteraAI Prostate Test
In this interview, Dr. McKay discusses use of the ArteraAI test for prostate cancer risk stratification. Dr. McKay is a GU me [...]
Florida medical tech company launches novel AI test for prostate cancer therapy
ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article